S18986
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for S18986, covering 2024-07-25 to 2024-07-25. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of S18986 in the Treatment of Mild Cognitive Impairment Patients [Phase 2]